NEORESIST
LIVE

Serial Number

79211993

Owner

SIEMENS HEALTHCARE GMBH

Attorney

Karla M. Weyand

Filing Date

Jan 25, 2017

Add to watchlist:

No watchlists yet
View on USPTO

NEORESIST Trademark

Serial Number: 79211993 • Registration: 5420630

NEORESIST is a trademark filed by SIEMENS HEALTHCARE GMBH on January 25, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

SIEMENS HEALTHCARE GMBH (383 trademarks)

Munchen 80333 , DE

Entity Type: 03

Trademark Details

Filing Date

January 25, 2017

Registration Date

March 13, 2018

Published for Opposition

December 26, 2017

Cancellation Date

September 27, 2024

Goods & Services

Scientific and technological services, namely, medical testing in the fields of identification, analysis and treatment of cancer and cancerous diseases for medical research purposes and new product research and design relating thereto; industrial analysis and research services in the fields of identification, analysis and treatment of cancer and cancerous diseases; scientific research for medical purposes; genetic and proteomic research studies of specimens; providing medical and scientific research in the fields of oncology, and molecular profiling, genomics and proteomics; conducting clinical trials for cancer research on behalf of others; design and development of computer hardware and computer software

Pharmaceutical preparations for the detection and analysis of cancer and veterinary preparations for the detection and analysis of cancer; diagnostic preparations for medical purposes; chemical preparations for analyses in laboratories, namely, chemical preparations for the analysis of cancer for medical or veterinary purposes; biological preparations for medical purposes, namely, for the detection, analysis and treatment of cancer; cultures of microorganisms for medical and veterinary use

Medical services, in particular medical analysis in connection with the diagnosis and treatment of cancer and cancerous diseases in individuals; medical testing for diagnosis and treatment of cancer and cancerous diseases provided by a medical laboratory; providing of information in the fields of medicine, veterinary medicine and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical services, namely, medical diagnostic, theranostic, prognostic and analytical services, including molecular diagnostics for the diagnosis and treatment of cancer and cancerous diseases

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Oct 24, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Oct 3, 2025 INTS
INVALIDATION PROCESSED
Oct 2, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
May 27, 2025 INTR
CANCELLED SECTION 71
Sep 27, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 13, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Sep 24, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 14, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 15, 2018 FICS
FINAL DISPOSITION PROCESSED
Jun 15, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 13, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 13, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 26, 2017 NPUB
PUBLISHED FOR OPPOSITION
Dec 26, 2017 PUBO
NOTIFICATION PROCESSED BY IB
Dec 22, 2017 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 6, 2017 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 6, 2017 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 6, 2017 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 17, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 6, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 6, 2017 CRFA
ASSIGNED TO LIE
Nov 1, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 23, 2017 TROA
REFUSAL PROCESSED BY IB
Aug 11, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 27, 2017 RFCS
REFUSAL PROCESSED BY MPU
Jul 27, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 22, 2017 RFCR
NON-FINAL ACTION WRITTEN
Jul 21, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 18, 2017 MAFR
ASSIGNED TO EXAMINER
Jul 14, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 14, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 13, 2017 REPR